Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …

This commentary discusses how clinicians and various stakeholders can utilize the recently
published American Association for the Study of Liver Diseases nonalcoholic fatty liver …

Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common chronic
liver disease globally and is currently estimated to affect up to 38% of the global adult …

The last years have witnessed the proposal, diagnostic criteria development, and
endorsement of a renewed fatty liver disease nomenclature, namely “metabolic dysfunction …

Metabolic-dysfunction associated steatotic liver disease (MASLD), previously known as non-
alcoholic fatty liver disease (NAFLD), is increasingly recognized as a prevalent global …

Metabolic dysfunction associated steatotic liver disease (MASLD) or previously known Non-
alcoholic fatty liver disease (NAFLD) is a common condition with an estimated global …

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as
nonalcoholic fatty liver disease (NAFLD), is the most common liver disease. It has a rapidly …

Abstract Background and Objective The aim of the present study is to explore the
epidemiologic impact of the definition of steatotic liver disease (SLD) proposed by a multi …

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as
nonalcoholic fatty liver disease (NAFLD), is a prevalent chronic liver disease worldwide …